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We read with interest the paper by Spragg et al. (1) regarding optimal
left ventricular (LV) endocardial pacing sites for cardiac resynchroni-
zation therapy in patients with ischemic cardiomyopathy.
However, we would like to challenge the authors’ conclusion
that “LV endocardial pacing is capable of dramatic improve-
ments in LV systolic function when the optimal site is stimu-
lated” and to offer the authors an alternative explanation for
their findings.
Although experimental data were not fully disclosed, it
appeared that standard epicardial coronary sinus pacing was
associated with an 20% increase in LV dP/dtmax compared
ith right ventricular apex (RVA) pacing. The best endocardial
acing site further improved LV dP/dtmax by 13%, yielding an
overall hemodynamic benefit (optimal endocardial site vs. RVA
pacing) of 36%. The fundamental problem is that LV sweet
spot was sought among a considerable number (51) of LV
endocardial sites and the correction for inherited statistical bias,
due to multiple measurements design together with biological
variability and non-zero analytical error of dP/dtmax assessment,
was not performed. It can easily be demonstrated by mathe-
matical modeling that a relatively small measurement error
projects into a rather wide range of extreme results. For
example, under the assumption that all endocardial LV pacing
sites have an invariable hemodynamic impact (dP/dtmax of
120% of RVA pacing, i.e., comparable to epicardial CS pacing)
and that the coefficient of variation for dP/dtmax measurements
s 6%, which is a quite realistic estimate, the 1,000-run
imulation experiment in 11 patients, each with 51 pacing sites
nalyzed, offers a mean dP/dtmax of 136% at “best” sites versus
VA pacing. Such a magnitude of improvement is identical to
hat observed and declared as a biological pacing site–specific
ffect in the mentioned study.
We thus wonder whether Spragg et al. (1) would agree that
ome of their findings might be significantly biased because
pparent hemodynamic improvement during LV endocardial
acing may predominantly originate from the statistical analysis
sed in their paper. Interestingly, another recent report on
ptimizing hemodynamics by LV endocardial pacing in patients
ith nonischemic dilated cardiomyopathy (2) used almost
dentical analytical methods that could similarly influence their
nterpretation favoring endocardial over the standard coronary
inus pacing.
An endocardial approach to cardiac resynchronization is cer-
ainly a promising concept, providing more flexibility in pacing site
election compared with standard epicardial biventricular pacing,
ut adequate experimental design and correct data analysis should
e prerequisites for valid conclusions.
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Reply
Drs. Wichterle and Vancura raise an interesting point in the
methodology of the recently published study by Spragg et al. (1) as
well as in our study (2) and question the validity of our conclusion.
We certainly agree that both the measurements and biological data
are subject to variability, which may introduce bias in such a study.
However, we think that these potential biases were limited by
rigorous methodology adopted in our study.
In our study, a limited number of left ventricular (LV) sites were
pre-defined and systematically assessed. The order of the pacing
protocol was randomized to minimize the detrimental effect of
time on the hemodynamic assessment. Baseline measurements
were performed in between pacing from each site. As stated in the
Methods section, hemodynamic results at each pacing site and the
mode were expressed as a percentage of variation from the control
that was defined as data from AAI pacing. Notably, these AAI
pacing data were remeasured immediately before each ventricular
pacing site was tested to account for hemodynamic alterations over
time.
Furthermore, 2 atrioventricular delays were sequentially
tested for each tested LV site, and general trends of site-specific
response to LV pacing were consistent for both atrioventricular
delays. Therefore, we agree that our study has some limitations
influencing the results, but we do not think that the method-
ology concerns raised by Drs. Wichterle and Vancura are
relevant to our study.
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